ClinicalTrials.gov
ClinicalTrials.gov Menu

Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00699777
Recruitment Status : Completed
First Posted : June 18, 2008
Last Update Posted : April 17, 2013
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Warner Chilcott

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2008
  Actual Study Completion Date : April 2008